Skip to main content

Table 3 Acute and elective surgery in individual specialties

From: suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients

  Acute surgery Elective surgery  
Type of surgery n (%)a Median suPAR 90-days mortality: n (%) n Median suPAR 90-days mortality: n (%) p-value suPARb p-value mortalityc
Gastroenterological 353 (68.7) 3.7 75 (21.3) 161 3.2 9 (5.6) 0.0032 < 0.0001
Orthopedic 320 (57.7) 4.3 61 (19.1) 235 2.8 5 (2.1) < 0.0001 < 0.0001
Cardiothoracic 111 (30.3) 2.8 8 (7.2) 255 2.6 3 (1.2) 0.16 0.0041d
Neurological 68 (44.7) 2.9 8 (11.8) 84 2.8 2 (2.4) 0.90 0.043d
Respiratory 357 (86.9) 4.4 131 (36.7) 54 3.1 5 (9.3) < 0.0001 < 0.0001
Urological 87 (41.6) 4.4 14 (16.1) 122 3.1 5 (4.1) < 0.0001 0.0029
Minor 381 (87.0) 4.5 114 (29.9) 57 3.8 4 (7.0) 0.065 0.0003
Endoscopies 764 (76.7) 4.2 145 (19.0) 230 3.3 11 (4.8) < 0.0001 < 0.0001
Gynecological 34 (34.7) 2.8 1 (2.9) 64 2.7 0 0.53 0.17
Obstetrics 231 (89.1) 1.6 0 28 1.8 0 0.50  
Vascular 54 (36.7) 4.1 12 (22.2) 93 4.2 1 (1.1) 0.96 < 0.0001
Dermatological 161 (80.5) 4.1 29 (18.0) 39 3.7 1 (2.6) 0.022 0.0153d
Other 10 (10.5) 2.5 1 (10.0) 85 2.8 2 (2.4) 0.71 0.19
Cancer-relatede 104 (40.5) 4.1 46 (44.2) 153 3.4 11 (7.2) 0.010 < 0.0001
  1. suPAR soluble urokinase plasminogen activator receptor
  2. aThe percentage of total surgery in the specific specialty
  3. bp-value is calculated for suPAR in acutely vs. electively operated patients
  4. cp-value is calculated for acute 90-day mortality compared with elective 90-day mortality
  5. dFisher’s exact test is used instead of Pearson’s Chi-squared test
  6. eCancer-related surgery is measured as the patient having cancer as the main diagnosis when surgery was performed